Jiangsu Changyou Environmental Protection Technology
301557
Hefei conver Holding
603409
LIERDA
832149
SHENGNAN TECHNOLOGY
837006
CHK
831167
CN Stock MarketDetailed Quotes
600056 China Meheco Group
- 10.60
- +0.03+0.28%
Market Closed Mar 4 15:00 CST
15.86BMarket Cap17.61P/E (TTM)
10.61High10.52Low84.57KlotVolume10.55Open10.57Pre Close89.39MTurnover0.57%Turnover Ratio15.12P/E (Static)1.50BShares13.8852wk High1.36P/B15.85BFloat Cap9.4552wk Low11.63Limit Up1.50BShs Float31.11Historical High9.51Limit Down0.85%Amplitude-1.82Historical Low0.23Dividend TTM10.57Avg Price41.33KlotAsk2.19%Div YieldTTM100Lot Size40.12KlotBid
China Meheco Group News
Announcement on the subsidiary obtaining approval for drug registration
Notice on progress in matters involving litigation
Announcement on the retirement and departure of company directors
Announcement of Resolutions of the 2025 First Extraordinary General Meeting of Shareholders
Legal Opinion on the 2025 First Extraordinary General Meeting of Shareholders of China Pharmaceutical and Health Industry Co., Ltd.
China Pharmaceutical: 2025 First Extraordinary General Meeting of Shareholders Meeting Information
2025 First Extraordinary General Meeting of Shareholders Meeting Materials
Announcement on the subsidiary\'s drug passing the generic drug consistency evaluation
China Pharmaceutical: Notice on Convening the First Extraordinary General Meeting of Shareholders in 2025
Notice on Convening the First Extraordinary General Meeting of Shareholders in 2025
Announcement on the subsidiary\'s drug passing the generic drug consistency evaluation
Announcement on receipt of the letter of commitment from the controlling shareholder
Announcement on the progress of the company\'s litigation matters
Announcement on the subsidiary participating in the 10th batch of national collection to be selected
Legal Opinion on the 5th Extraordinary General Meeting of Shareholders of China Pharmaceutical and Health Industry Co., Ltd. in 2024
Announcement of Resolutions of the Fifth Extraordinary General Meeting of Shareholders in 2024
China Pharmaceutical: 2024 Fifth Extraordinary General Meeting of Shareholders Meeting Information
Announcement on the subsidiary obtaining approval for drug registration
2024 Fifth Extraordinary General Meeting of Shareholders Meeting Materials
Notice on Subsidiaries Obtaining Approval Notice for Drug Supplementation Applications
